By vgreene, 20 June, 2019 Each bold header is an indication or use for the product, with appropriate dosing found under each.
By vgreene, 20 June, 2019 FDA-approved indications and off-label uses for prescription (Rx) drugs can be found under the Adult and Peds Dosing sections in Epocrates drug monographs.
By vgreene, 20 June, 2019 We developed the Notes functionality so that individual users could customize Epocrates drug monographs for their own needs and practice settings.
By vgreene, 20 June, 2019 We encourage use of the Notes section of a drug monograph to record IV administration information for frequently ordered and administered drugs.
By vgreene, 20 June, 2019 If an ADR doesn’t meet our inclusion criteria as a serious or common ADR, but that ADR is nonetheless serious, severe, frequent, and/or is strongly associated with the use of the drug, it will be included at the end of the Common Reactions.
By vgreene, 20 June, 2019 Editors also assess other factors when determining which ADRs to list in the Common Reactions section, including seriousness, severity, frequency, and strength of causal association with the drug.
By vgreene, 20 June, 2019 However, the greater than or equal to 2% standard may vary for products in which such information isn’t available, reported differently (eg, listed as >1% or >5% in the product labeling), or studied versus an active control. We’ve found that the 2% cut-of
By vgreene, 20 June, 2019 Common Reactions also include any ADR referred to as “frequent,” “common,” or “most common” in the product labeling or primary literature.